Skip to main content

Omega Therapeutics, Inc.

OMGADelisted Mar 20, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850838

Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.

Superinvestors holding OMGA, Q4 2024

See all superinvestors

No superinvestor reported holding OMGA in Q4 2024.